Sun, Dec 21, 2014, 11:04 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Bio-Matrix Scientific Group, Inc. Message Board

  • bobradcliff77777 bobradcliff77777 Feb 28, 2013 9:00 AM Flag

    Google the text and find it yourself. It is here. FDA news

    2013 FDA Calender, Latest Clinical Trial Results And Biotech News Along With Biotech Stocks Forecast and Predictions
    Biotech News Stock Review Breaks It First!_Approval Granted_Bio-Matrix Scientific Group (BMSN) Sails Through FDA Investigational New Drug (IND) Process, Next Orphan Drug Designation Predicts Biotech News Stock Review.

    Johnny is hearing from his very reliable sources that the FDA is shortly going to release the good news that BMSN shareholders have been waiting for, APPROVAL for HemaXellerate to move on and proceed with clinical trials. Wait for official word and then enjoy the ride shareholders of BMSN, check back for more updates!
    Biotech Stock Share Price Rise Or Fall Projections For Week Of February 25th To March 1st 2013.

    Utilizing a unique complex Japanese based technical indicator formula that has consistently yielded a 92% success accuracy rate here are Adam and Johnny’s forecasts for the coming week, before you freak out remember these stock calls are for the entire week. In other words a stock that is rated to go up will end up higher at the end of the week than it started and a stock rated lower will see it’s share price decline at week end from where it began! Caveat, these calls are based on current technical indicators, ANY POSITIVE NEWS is likely to override these forecasts!

    Dynavax (DVAX) UP
    Amarantus BioScience (AMBS) UP
    Bio-Matrix Scientific Group (BMSN) DOWN
    Arena Pharmaceuticals (ARNA) UP
    Peregrine Pharmaceuticals (PPHM) UP
    Every week we publish our highly accurate calls for about 20 biotech stocks. Our selections will almost always be higher or lower at the end of the week as we forecast, check back for our weekly picks.
    FDA Approval Calender 2013

    02/24/2013-Dynavax ”Heplisav”-Hepatitis B Vaccine-FDA Approval Decision
    02/26/2013-Immunogen “Trastuzumab emtansine”-breast cancer-FDA Approval Decision
    02/28/2013-Onyx Pharmaceuticals”Stivarga” -Gastrointestinal Stromal Tumors-FDA Approval Decision
    03/01/2013-Zogenix ”Zohydro ER” -severe chronic pain-FDA Approval Decision
    03/04/2013-DEPOMED ”Serada” - menopausal hot flashes-FDA Advisory Committee Meeting
    03/07/2013-GlaxoSmithKline “BREO ELLIPTA” -chronic obstructive pulmonary disease-FDA Advisory Committee Meeting
    03/27/2013-Ariad Pharmaceuticals “Ponatinib” -myeloid/lymphoblastic leukemia-FDA Approval Decision
    03/27/2013-AP Pharma ”APF530″ -chemotherapy-induced nausea -FDA Approval Decision
    03/31/2013-United Therapeutics “Oral Treprostinil” -pulmonary arterial hypertension-FDA Approval Decision
    03/31/2013-Arena Pharmaceuticals “Belviq”-Obesity-EMA CHMP Panel Result
    03/31/2013-Johnson & Johnson ”INVOKANA”-type 2 diabetes-FDA Approval Decision
    04/15/2013-MAP PHARMACEUTICALS “LEVADEX” -migraine in adults-FDA Approval Decision

    04/30/2013-Raptor Pharmaceuticals ”RP103″-nephropathic cystinosis-FDA Approval Decision
    04/30/2013-Navidea Biopharmaceuticals “Lymphoseek”-lymphatic mapping procedures-FDA Approval Decision
    05/12/2013-THERAVANCE ”Fluticasone furoate” -obstructive pulmonary disease-FDA Approval Decision
    5/24/2013-Valeant Pharmaceuticals “Efinaconazole”-Toenail fungus infection-FDA Approval Decision
    05/31/13-Affymax “Omontys”-Anemia in Kidney Dialysis Patients-EMA CHMP Panel Result
    5/31/2013-Depomed “Serada”-menopausal hot flashes-FDA Approval Decision
    05/31/13-Sanofi “Aubagio”-Multiple Sclerosis-EMA CHMP Panel Result
    6/3/2013-GlaxoSmithKline “Dabrafenib”-Melanoma-FDA Approval Decision
    6/3/2013-GlaxoSmithKline “Trametinib”-Melanoma-FDA Approval Decision
    6/14/2013-Delcath Systems “ChemoSat”-Liver mets due to melanoma-FDA Approval Decision
    06/30/2013-AVEO Pharmaceuticals “Tivopath”-Renal Cell Cancer-FDA Advisory Committee Meeting
    06/30/2013-Biogen “BG-12″-Multiple Sclerosis-EMA CHMP Panel Result
    07/01/2013-Merck “Suvorexant”-Insomnia-FDA Approval Decision
    7/26/2013-AVEO Pharmaceuticals “Tivopath”-Renal Cell Cancer-FDA Approval Decision
    7/26/2013-Forest Laboratories “evomilnacipran”-Depression-FDA Approval Decision
    08/31/13-Ariad Pharmaceuticals “Iclusig”-Acute Lymphocytic Leukemia-EMA CHMP Panel Result
    08/31/13-Celgene “Pomalyst”-Multiple Myeloma-EMA CHMP Panel Result
    9/6/2013-Auxilium Pharmaceuticals “Xiaflex”-Peyronie’s Disease-FDA Approval Decision
    12/17/2013-Antares Pharma “Otrexup”-Rheumatoid Arthritis-FDA Approval Decision
    12/17/2013-GlaxoSmithKline “Dolutegravir”-HIV / AIDS-FDA Approval Decision

    About Biotech News Stock Review
    Adam and Johnny both love investing in biotech stocks, especially small companies that have promising drug pipelines.

    Adam is an avid researcher and very meticulous in his stock selections, Adam previously worked for Sierra World Equity Review where he was instrumental in helping select numerous accurate FDA calls. Adam has a law degree from Yale and is also fluent in Mandarin which he studied at the University of Beijing.

    Johnny is a executive for a large pharmaceutical company based in New Jersey, with years of experience in his position as Managing Director for mergers and acquisitions with with special focus on China, Johnny brings valuable insight and perspective to the blogs daily stock posts.

    If you enjoy buying and selling stocks, occasionally trade stocks online and enjoy the thrill of seeing your stock breakout after positive FDA trial results, then perhaps you may enjoy our blog! To maintain impartiality we never hold positions in any of the stocks we blog about.

    Biotech News Stock Review Blog
    What Stock Adam And Johnny Are Long On But Do Not Blog About – Read the independent, DD it will blow you away-1000% Gains Likely This Year!
    Disclaimer and Privacy Policy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.0007-0.0001(-12.50%)Dec 19 3:37 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.